| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ViewRay Inc (NASDAQ: VRAY)
VRAY Technical Analysis
5
| As on 26th Sep 2023 VRAY STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.76 & Strong Sell for SHORT-TERM with Stoploss of 3.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VRAYSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | 0.00 | 0.00 |
| Volume | 2322230 | 1 Year | -3.91 | -99.74 |
| 52 Week High 4.82 | 52 Week Low 0.01 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| APTO | 0.28 | 64.71% |
| NVDA | 134.70 | 3.08% |
| TNXP | 0.61 | 7.02% |
| LCID | 3.02 | 14.83% |
| TAOP | 0.41 | 28.12% |
| AVGO | 220.79 | 1.13% |
| TSLA | 421.06 | -3.46% |
| QUBT | 17.62 | 16.38% |
| AAPL | 254.49 | 1.88% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VRAY Daily Charts |
VRAY Intraday Charts |
Whats New @ Bazaartrend |
VRAY Free Analysis |
|
|
VRAY Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
VRAY Forecast December 2024
| 4th UP Forecast | 1.86 |
| 3rd UP Forecast | 1.27 |
| 2nd UP Forecast | 0.9 |
| 1st UP Forecast | 0.53 |
| 1st DOWN Forecast | -0.51 |
| 2nd DOWN Forecast | -0.88 |
| 3rd DOWN Forecast | -1.25 |
| 4th DOWN Forecast | -1.84 |
VRAY Weekly Forecast
| 4th UP Forecast | 1.11 |
| 3rd UP Forecast | 0.76 |
| 2nd UP Forecast | 0.54 |
| 1st UP Forecast | 0.32 |
| 1st DOWN Forecast | -0.30 |
| 2nd DOWN Forecast | -0.52 |
| 3rd DOWN Forecast | -0.74 |
| 4th DOWN Forecast | -1.09 |
VRAY Forecast2024
| 4th UP Forecast | 9.55 |
| 3rd UP Forecast | 6.49 |
| 2nd UP Forecast | 4.6 |
| 1st UP Forecast | 2.71 |
| 1st DOWN Forecast | -2.69 |
| 2nd DOWN Forecast | -4.58 |
| 3rd DOWN Forecast | -6.47 |
| 4th DOWN Forecast | -9.53 |
ViewRay Inc ( NASDAQ USA Symbol : VRAY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VRAY Business Profile
ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio. Address: 2 Thermo Fisher Way, Oakwood, OH, United States, 44146
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service